ACT-132577
ACT-132577 Basic information
- Product Name:
- ACT-132577
- Synonyms:
-
- N-Despropyl Macitentan
- Aprocitentan
- 5-(4-BROMOPHENYL)-4-[2-(5-BROMOPYRIMIDIN-2-YL)OXYETHOXY]-6-(SULFAMOYLAMINO)PYRIMIDINE
- ACT-132577
- N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]sulfamide
- APROCITENTAN; ACT-132577; ACT 132577; ACT132577; DESPROPYL MACITENTAN
- Despropyl Macitentan
- Macitentan N-Despropyl Impurity
- CAS:
- 1103522-45-7
- MF:
- C16H14Br2N6O4S
- MW:
- 546.19
- Product Categories:
-
- APIS
- API
- Mol File:
- 1103522-45-7.mol
ACT-132577 Chemical Properties
- Melting point:
- 139-141°C
- Boiling point:
- 705.0±70.0 °C(Predicted)
- Density
- 1.841±0.06 g/cm3(Predicted)
- storage temp.
- -20°C Freezer
- solubility
- Chloroform (Slightly, Heated), Methanol (Slightly, Heated)
- form
- Solid
- pka
- 13.56±0.60(Predicted)
- color
- White to Off-White
- InChI
- InChI=1S/C16H14Br2N6O4S/c17-11-3-1-10(2-4-11)13-14(24-29(19,25)26)22-9-23-15(13)27-5-6-28-16-20-7-12(18)8-21-16/h1-4,7-9H,5-6H2,(H2,19,25,26)(H,22,23,24)
- InChIKey
- DKULOVKANLVDEA-UHFFFAOYSA-N
- SMILES
- S(NC1C(C2=CC=C(Br)C=C2)=C(OCCOC2=NC=C(Br)C=N2)N=CN=1)(N)(=O)=O
ACT-132577 Usage And Synthesis
Uses
N-Despropyl-macitentan, is an active metabolite which is part of a family of endothelin receptor antagonist that allows for treatment of pulmonary arterial hypertension (PAH)
Definition
ChEBI: ACT-132577 is a member of the class of sulfamides in which one of the amino groups of sulfonamide is substituted by a 5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl group. An active metabolite of macitentan (obtained by oxidative depropylation), an orphan drug used for the treatment of pulmonary arterial hypertension. It has a role as an antihypertensive agent, an endothelin receptor antagonist, a drug metabolite and a xenobiotic metabolite. It is an aromatic ether, an organobromine compound, a member of pyrimidines and a member of sulfamides. It is functionally related to an ethylene glycol.
in vivo
Aprocitentan (ACT-132577) has a volume of distribution greater than the plasma volume and a longer half-life than its parent compound in the rat[1]. In rat plasma, the mean recovery of Aprocitentan (ACT-132577) ranges from 82.6% to 90.6%, matrix effect of Aprocitentan (ACT-132577) in rat plasma ranges from 101.4% to 115.2%[2].
IC 50
ETA: 3.4 nM (IC50); ETA: 6.7 (pA2); ETB: 987 nM (IC50); ETB: 5.5 (pA2)
ACT-132577Supplier
- Tel
- 0551-68933033 13956024211
- trchem@163.com
- Tel
- +21-18501659228 18501659228
- info@hope-chem.com
- Tel
- 0531-88110457; 18954159893
- demi@pharmachemm.com
- Tel
- 15189836218
- wedo-chem@huawe.com
- Tel
- hanfangpharma@126.com; 18616537568
- hanfangpharma@126.com